Discontinued Operations

6 Months Ended

Mar. 31, 2013

discontinued operation income loss from discontinued operation

disposalgroupsincludingdiscontinuedoperationsdisclosuretextblock

Note 2. Discontinued Operations

The Company is committed to a plan to divest its packaging and clinical trials services business, AndersonBrecon (“AB”), to allow it to focus on its distribution, specialty, and manufacturer services businesses. In March 2013, the Company also committed to a plan to divest AmerisourceBergen Canada Corporation (“ABCC”) due to the challenging economic environment of Canadian pharmaceutical distribution.The Company has classified AB and ABCC's assets and liabilities as held for sale in the accompanying consolidated balance sheets and has classified AB and ABCC's operating results, net of tax, as discontinued operations in the accompanying consolidated statements of operations for all periods presented. Previously, AB was included in Other and ABCC was included in Pharmaceutical Distribution for segment reporting. AB and ABCC's revenue and loss before income taxes were as follows:

		Three months ended March 31,				Six months ended March 31,
(in thousands)		2013		2012	2013		2012
Revenue	$	441,277	$	368,378	$	915,508	$	751,904
Loss before income taxes	$	(154,561)	$	(9,491)	$	(156,613)	$	(8,285)

The loss before income taxes in the three and six months ended March 31, 2013 includes a goodwill impairment charge of $26.9 million and an estimated $134.8 million loss on the sale of ABCC.

The following table summarizes the assets and liabilities of AB and ABCC (in thousands):

		March 31,		September 30,
		2013		2012
Assets:
	Accounts receivable	$	173,958	$	187,179
	Merchandise inventories		210,999		249,463
	Property and equipment, net		135,630		131,907
	Goodwill and other intangible assets		54,481		85,163
	Other assets		6,691		9,141
	Valuation allowance		(119,984)		-
Assets held for sale			461,775		662,853
Liabilities:
	Accounts payable		144,747		152,110
	Accrued expenses and other		29,218		16,554
	Other liabilities		38,273		71,042
Liabilities held for sale			212,238		239,706
Net assets		$	249,537	$	423,147